Literature DB >> 31185221

Primary prevention of severe lower respiratory illnesses in at-risk infants using the immunomodulator OM-85.

Peter D Sly1, Sally Galbraith2, Zahir Islam2, Barbara Holt3, Niamh Troy3, Patrick G Holt3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31185221     DOI： 10.1016/j.jaci.2019.05.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

Review 1.  Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions.

Authors:  Désirée Larenas-Linnemann; Noel Rodríguez-Pérez; Alfredo Arias-Cruz; María Virginia Blandón-Vijil; Blanca E Del Río-Navarro; Alan Estrada-Cardona; José E Gereda; Jorge A Luna-Pech; Elsy Maureen Navarrete-Rodríguez; Ernesto Onuma-Takane; César Fireth Pozo-Beltrán; María Isabel Rojo-Gutiérrez
Journal:  World Allergy Organ J       Date:  2020-10-09       Impact factor: 4.084

Review 2.  Prevention of Asthma: Targets for Intervention.

Authors:  Michelle C Maciag; Wanda Phipatanakul
Journal:  Chest       Date:  2020-04-21       Impact factor: 9.410

3.  Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axis.

Authors:  Vadim Pivniouk; Joao A Gimenes-Junior; Peace Ezeh; Ashley Michael; Oksana Pivniouk; Seongmin Hahn; Sydney R VanLinden; Sean P Malone; Amir Abidov; Dayna Anderson; Justyna Gozdz; Avery DeVries; Fernando D Martinez; Christian Pasquali; Donata Vercelli
Journal:  J Allergy Clin Immunol       Date:  2021-09-22       Impact factor: 10.793

Review 4.  Promising Immunomodulatory Effects of Bacterial Lysates in Allergic Diseases.

Authors:  Agnieszka Kaczynska; Martyna Klosinska; Kamil Janeczek; Michał Zarobkiewicz; Andrzej Emeryk
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

5.  Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.

Authors:  Geertje M de Boer; Gert-Jan Braunstahl; Esmee K van der Ploeg; Cathelijne M van Zelst; Alie van Bruggen; Guido Epping; Menno van Nimwegen; Gert Verhoeven; Erwin Birnie; Bianca M Boxma-de Klerk; Marjolein J W de Bruijn; Ralph Stadhouders; Rudi W Hendriks; Gerdien A Tramper-Stranders
Journal:  Clin Exp Allergy       Date:  2021-08-06       Impact factor: 5.401

Review 6.  A Precision Medicine Approach to SARS-CoV-2 Pandemic Management.

Authors:  Carlos D Crisci; Ledit R F Ardusso; Antonela Mossuz; Leila Müller
Journal:  Curr Treat Options Allergy       Date:  2020-05-08

7.  Distinct Antiviral Properties of Two Different Bacterial Lysates.

Authors:  Michael Roth; Hanif J Khameneh; Lei Fang; Michael Tamm; Giovanni A Rossi
Journal:  Can Respir J       Date:  2021-02-04       Impact factor: 2.409

8.  Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis.

Authors:  Changqing Cao; Jinghua Wang; Yuning Li; Yumei Li; Liyan Ma; Mohamed E A Abdelrahim; Yi Zhu
Journal:  Int J Clin Pract       Date:  2021-01-22       Impact factor: 3.149
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.